Phase II 177Lu-DOTATATE Study in Metastatic NPC With a Safety Run-in
Clinical trial NCT05198479 · SUSPENDED
Trial details
- NCT number
- NCT05198479
- Sponsor
- National Cancer Centre, Singapore
- Status
- SUSPENDED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-05
- Primary completion
- 2026-12-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.